CID 132712

Bibn 99

Structural Information

Molecular Formula
C31H42ClN5O3
SMILES
CCCC(C)(C)C(=O)N(CC)CCCC1CCN(CC1)CC(=O)N2C3=C(C=C(C=C3)Cl)C(=O)NC4=C2N=CC=C4
InChI
InChI=1S/C31H42ClN5O3/c1-5-15-31(3,4)30(40)36(6-2)17-8-9-22-13-18-35(19-14-22)21-27(38)37-26-12-11-23(32)20-24(26)29(39)34-25-10-7-16-33-28(25)37/h7,10-12,16,20,22H,5-6,8-9,13-15,17-19,21H2,1-4H3,(H,34,39)
InChIKey
LUPAFPUKESJDMZ-UHFFFAOYSA-N
Compound name
N-[3-[1-[2-(8-chloro-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepin-11-yl)-2-oxoethyl]piperidin-4-yl]propyl]-N-ethyl-2,2-dimethylpentanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

11
References

188
Patents

567.2976 Da
Monoisotopic Mass

4.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 568.30488 238.1
[M+Na]+ 590.28682 246.2
[M+NH4]+ 585.33142 240.7
[M+K]+ 606.26076 240.8
[M-H]- 566.29032 238.7
[M+Na-2H]- 588.27227 238.7
[M]+ 567.29705 239.4
[M]- 567.29815 239.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe